Searchable abstracts of presentations at key conferences in endocrinology

ea0090p665 | Endocrine-related Cancer | ECE2023

A rare cause of bilateral adrenal masses

Santos Sara , Calheiros Raquel , Souteiro Pedro , Oliveira Joana , Inacio Isabel , P Santos Ana , Torres Isabel

Introduction: Bilateral adrenal masses may appear in the context of metastatic disease, adrenal congenital hyperplasia, primary tumors or infections, among others. Primary adrenal lymphoma is rare, accounting for approximately 1% of cases of non-Hodgkin lymphoma. Clinical case: 47-year-old woman, with a history of erythema nodosum and left hemithyroidectomy in the context of benign nodular disease. She presented with persistent fever and tiredne...

ea0090ep83 | Adrenal and Cardiovascular Endocrinology | ECE2023

Primary adrenal insufficiency in the context of small-cell neuroendocrine prostate cancer

de Brito Marques Francisca , Magalhaes Helena , Ferreira Joana Lima , de Carvalho Francisco Simoes , Marques Ana Paula

Introduction: The small-cell neuroendocrine prostate carcinoma (SCPC) is rare, highly aggressive and usually transforms from prostate adenocarcinoma (PAC) after androgen deprivation therapy (ADT).Case Report: A 66-year-old man had a three-year history of high-grade PAC with high burden disease (abdominal lymph node and bone metastasis) at presentation (09/2019). On the initial staging evaluation, the CT scan documented a 20 mm left adrenal nodule compati...

ea0090ep188 | Calcium and Bone | ECE2023

22q11.2 deletion syndrome diagnosed in the context of a seizure in adulthood

de Brito Marques Francisca , Simoes de Carvalho Francisco , Ferreira Joana Lima

Introduction: The 22q11.2 deletion syndrome or DiGeorge syndrome (DGS) is rare and the diagnosis in adults is uncommon. The phenotype is highly heterogeneous and of variable severity, including hypoparathyroidism and epilepsy.Case Report: A 26-year-old man was admitted in the emergency room for inaugural tonic-clonic seizure. He had history of cognitive impairment and learning difficulties. Neurologic examination, brain CT and basic analysis were irrelev...

ea0090ep828 | Pituitary and Neuroendocrinology | ECE2023

Panhypopituitarism of unknown aetiology in a young adult – a case report

Souteiro Pedro , Santos Sara , Oliveira Joana , Inacio Isabel , P Santos Ana , Torres Isabel

Introduction: Hypopituitarism is a rare diagnosis that is mainly due to primary pituitary neoplasms and their treatment. There are rarer causes such as hemorrhage/ischemia, traumatic brain injury, infections and infiltrative lesions. Clinical case: We herein present an 18-year-old male patient diagnosed with acute promyelocytic leukemia at the age of 14, with no evidence of central nervous system invasion in several lumbar punctures during his follow-up....

ea0090ep1061 | Thyroid | ECE2023

Prolonged Survival in Follicular Thyroid Cancer with Bone Metastasis

de Brito Marques Francisca , Simoes de Carvalho Francisco , Lima Ferreira Joana , Paula Marques Ana

Introduction: Follicular thyroid cancer (FTC) accounts for 12% of differentiated thyroid cancers (DTC). It is frequently complicated by bone metastasis (BM), which impact quality of life (QOL) and decreases the 10-year survival rate to 13-21%.Case Report: A 53-year-old woman followed at the Pain Clinic for over 10 years for lower back pain, had been operated three years before due to lumbar disc herniation. Pain relapsed one year after surgery and was re...

ea0063p670 | Interdisciplinary Endocrinology 1 | ECE2019

The impact of new technologies in the future of health somatotropin: 100% therapeutic adhesion in oncological pediatric age survivors in the Ipolfg

Sonia Andrade , Filipa Matos , Joana Simoes-Pereira , Conceicao Pereira Maria da

Introduction: The somatotropin deficit is one of the late consequences of cancer treatments. The administration of somatotropin implies treatment with daily injections, which hinders therapeutic adherence. This goal is a challenge for survivors and health professionals. Therapeutic education and new technologies are instruments that favor the training and development of control mechanisms that promote and motivate the behavior’s change.Objective: To...

ea0063p875 | Adrenal and Neuroendocrine Tumours 3 | ECE2019

Clinical spectrum of MEN1: what about other non-endocrine neoplasias?

Marques Bernardo , Martins Raquel G , Elvas Ana Rita , Couto Joana , Santos Jacinta , Martins Teresa , Rodrigues Fernando

Introduction: Multiple endocrine neoplasia type 1 syndrome (MEN1) is a hereditary autosomal dominant disorder caused by germline mutations in the MEN1 tumour-suppressor gene and is typically characterized by parathyroid adenomas, duodenopancreatic neuroendocrine tumors (NETs) and pituitary adenomas. Breast cancer has recently been identified as manifestation of MEN1 and female patients have early onset elevated breast cancer risk.Case report: Female pati...

ea0063p1028 | Interdisciplinary Endocrinology 2 | ECE2019

Impact of hormonal factors in the genesis of sarcopenia

Mascarenhas Mario Rui , Barbosa Ana Paula , Fortes Indira , Ferreira Joana , Bicho Manuel

The European Working Group on Sarcopenia in Older People (EWGSOP2) defined in 2018 ‘sarcopenia as muscle disease (muscle failure), with low muscle strength overtaking the role of low muscle mass as a principal determinant’; sarcopenia increases risk of falls and fractures, impairs ability to perform activities of daily living, leads to mobility disorders and low quality of life and death. The diagnosis is confirmed by low muscle quantity or quality. The muscle quanti...

ea0063p1191 | Thyroid 3 | ECE2019

Differentiated thyroid cancer treated with lobectomy: assessment of response to therapy

Rodrigues Fernando Elvas Ana Rita , Martins Raquel G , Couto Joana , Santos Jacinta , Martins Teresa , Rodrigues Fernando

Background: Assessment of response to therapy is a valid tool for dynamic risk stratification in patients with differentiated thyroid cancer (DTC). It is well documented in patients treated with total thyroidectomy and radioiodine ablation therapy (RAI), but data is still sparse regarding patients treated with lobectomy. Our study aimed to evaluate response to therapy in patients with DTC treated with lobectomy.Methods: We performed a retrospective study...

ea0063p1195 | Thyroid 3 | ECE2019

Amiodarone-induced thyrotoxicosis: when combined treatment is an option

Silva Diana , Ruas Luisa , Cunha Nelson , Catarino Diana , Fadiga Lucia , Guiomar Joana , Carrilho Francisco

Introduction: Amiodarone is an effective drug in the management of supraventricular arrhythmias. Due to its composition rich in iodine and pharmacological properties can cause thyroid dysfunction in 15–20% of the treated patients. Clinically it can present in the form of amiodarone-induced hypothyroidism or amiodarone-induced thyrotoxicosis. This latter situation may result from an excess of iodine supply, glandular destruction or both pathogenic mechanisms.<p class="...